As of Feb 12
| +0.14 / +3.64%|
The 6 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 9.50, with a high estimate of 18.00 and a low estimate of 6.00. The median estimate represents a +138.10% increase from the last price of 3.99.
The current consensus among 7 polled investment analysts is to Buy stock in Raptor Pharmaceutical Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.